Atrandi Biosciences
Vilnius, LT · Founded 2016 · 79 employees on LinkedIn · 6 known investors
Find your way into Atrandi Biosciences
Atrandi makes Flux, a device that isolates thousands to hundreds of thousands of individual cells simultaneously into semi-permeable capsules for downstream genomic and microbial analysis. The system is designed for life science research and can operate in field settings or laboratory environments.
Investors · 6
GRIDS Capital✓ verifiedSão Paulo
Lux Capital✓ verifiedNew York · $100K – $100M
Metaplanet✓ verifiedTallinn · $500K – $10M
Practica Capital✓ verifiedVilnius · $324K – $3.2M
Vsquared VenturesMünchen
Also in the syndicate · 1
CRIDS Capital
Funding
SEC filings, press & company announcements$25M disclosed across 1 round · 2025
- $25MSeries AFeb 2025 · 3 sources
Lux Capital (lead), CRIDS Capital, GRIDS Capital, Metaplanet, Practica Capital, Vsquared Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Atrandi Biosciences do?
- Atrandi makes Flux, a device that isolates thousands to hundreds of thousands of individual cells simultaneously into semi-permeable capsules for downstream genomic and microbial analysis. The system is designed for life science research and can operate in field settings or laboratory environments.
- Who are Atrandi Biosciences's investors?
- Atrandi Biosciences's investors include GRIDS Capital, Lux Capital, Metaplanet, Practica Capital, Vsquared Ventures.
- How much funding has Atrandi Biosciences raised?
- Atrandi Biosciences has disclosed $25M raised across 1 round.
- Where is Atrandi Biosciences headquartered?
- Atrandi Biosciences is headquartered in Vilnius, LT.